Breast-conserving therapy (BCT) for early-stage breast cancer
β Scribed by Rashmi K. Benda; Nancy Price Mendenhall; D. Scott Lind; Juan C. Cendan; Barbara F. Shea; Lisa C. Richardson; Edward M. Copeland III
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 188 KB
- Volume
- 85
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Several patient and tumor factors go into the decision process to determine whether a breast cancer patient is a good candidate for breastβconserving therapy. The patient must be seen by all disciplines before any therapeutic intervention. When used appropriately, breastβconserving therapy produces maximal disease control and improves quality of life in patients with earlyβstage breast cancer. J. Surg. Oncol. 2004;85:14β27. Β© 2003 WileyβLiss, Inc.
π SIMILAR VOLUMES
up for surviving patients was 95 months (range, 68-157 months). Pathology slides were available for review in 19 cases. Cosmetic results and complications after 1 Joint Center for Radiation Therapy and Depart-BCT were scored. Outcome was compared with that of 1314 patients with unilateral ment of Ra
## Abstract ## BACKGROUND Multiple treatment guidelines and practice standards have been developed regarding the management of patients with breast carcinoma. Few evaluations of the penetration and utility of these practice standards have been performed. In 1992, the American College of Surgeons (